Stay updated on Merck & Co. Press Releases

Sign up to get notified when there's something new on the Merck & Co. Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Merck & Co. Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    The news release list adds an announcement about Merck’s third-quarter 2026 earnings call and a report that tulisokibart met key endpoints in a Phase 2b study. The displayed total increases from 1,961 to 1,963 releases.
    Difference
    5%
    Check dated 2026-10-07T01:18:01.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    New items have been added to the News releases page, including a global license agreement with SciBrunch Therapeutics for SPR2015, withdrawal of the Ifinatamab Deruxtecan BLA for extensive-stage SCLC, FDA approval of WELIREG plus LENVIMA for ccRCC, and Remigromig showing positive results in diabetic macular edema. Older posts have been removed from the listing to maintain a current-news focus.
    Difference
    5%
    Check dated 2026-09-30T01:34:37.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Three new press releases dated September 22, 2026; September 21, 2026; and September 18, 2026 have been added to the News releases list, expanding the current roster of Merck's announcements. Older releases from July 2026 were removed from the listing.
    Difference
    5%
    Check dated 2026-09-23T01:11:26.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Updated the audience navigation label from 'For patients and health care professionals' to 'For patients and healthcare professionals'. This aligns the phrasing and improves readability in the site's navigation.
    Difference
    1%
    Check dated 2026-09-16T00:30:12.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Two new items announce Merck's participation in upcoming healthcare conferences (Morgan Stanley and Wells Fargo). The feed also shows pagination, and two KEYTRUDA-related press releases were removed from the list.
    Difference
    6%
    Check dated 2026-09-08T23:04:53.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A new August 19, 2026 news release about the INTerpath-001 trial of Intismeran Autogene Plus with KEYTRUDA reports RFS and DMFS endpoints in completely resected melanoma, added to the News releases feed. The July 1, 2026 item about Merck's Q2 conference call was removed from the list of news releases.
    Difference
    5%
    Check dated 2026-08-25T22:15:08.000Z thumbnail image

Stay in the know with updates to Merck & Co. Press Releases

Enter your email address, and we'll notify you when there's something new on the Merck & Co. Press Releases page.